钾离子通道多聚体结构域蛋白12抗体
C13orf2; BTB/POZ domain-containing protein KCTD12; C13orf2; KCD12_HUMAN; KCTD12; KIAA1778; PFET1; Pfetin; potassium channel tetramerisation domain containing 12 USA; Predominantly fetal expressed T1 d
羰基还原酶1抗体
15 hydroxyprostaglandin dehydrogenase [NADP+]; 15-hydroxyprostaglandin dehydrogenase [NADP+]; Carbonyl reductase [NADPH] 1; Carbonyl Reductase 1; CBR 1; CBR1; CBR1_HUMAN; CRN; NADPH dependent
乳腺癌抗雌激素抵抗蛋白2抗体
BCAR2; Breast cancer anti estrogen resistance 2; Breast cancer anti-estrogen resistance 2; RAPA; rapa 1; rapa 2; rapa1; rapa2; RP1 139D8.5; Transcriptional regulating factor 1; Transcriptional regulat
Anti-PRLR Polyclonal Antibody
Anti-PRLR Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:25-100. 交叉反应 Human
着丝粒相关蛋白E抗体
CENP E; Centromere associated protein E; Centromere autoantigen E (312kD); Centromere autoantigen E; Centromere protein E 312kDa; Centromere protein E; Centromeric protein E; KIF10; Kinesin fa
卷曲螺旋结构域蛋白148抗体
CCDC 148; coiled coil domain containing 148; coiled-coil domain containing 148; CC148_HUMAN.
程序性细胞死亡2样抗体
PDCD2L; MGC144595; MGC13096; Programmed cell death 2 like; Programmed cell death protein 2 like; PDD2L_HUMAN.
RNA结合蛋白38抗体
SEB4D; CLL associated antigen KW 5; CLL-associated antigen KW-5; HSRNASEB; RBM38; RBM38_HUMAN; RNA binding motif protein 38; RNA binding protein 38; RNA binding region (RNP1, RRM) containing 1; RNA bi